Speyside supported a global pharmaceutical company in assessing Argentina, Colombia, and Mexico’s readiness for a lung cancer screening program. The project involved analyzing the regulatory landscape, identifying policy gaps, and collaborating with advocacy groups and the scientific community to develop actionable recommendations. Deliverables included a saved lives calculator, communications toolkit, policy report, and a recommendations blueprint to guide future policymaker engagement.

A global pharmaceutical company sought Speyside’s support to assess Argentina, Colombia, and Mexico’s readiness for a lung cancer screening program.

The general goal was to understand the regulatory landscape surrounding lung cancer detection and provide a series of policy recommendations on how a screening program could be implemented and a general policy plan to reach said goal.

Speyside designed a local assessment strategy, in which the regulatory situation was diagnosed, as well as the general situation of the disease in the country.

The Speyside team developed a policy report in which a diagnosis of the situation was presented, as well as the policy gaps.

The team collaborated with local advocacy groups and scientific community to build a series of policy recommendations that the company’s team can use in future engagements with policy makers.

• Saved lives calculator.
• Communications toolkit.
• Policy report.
• Recommendations blueprint report.